Related Experiment Video

Updated: May 24, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Management of children exposed to multidrug-resistant Mycobacterium tuberculosis

James A Seddon1, Peter Godfrey-Faussett, Anneke C Hesseling

  • 1Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK . jseddon@sun.ac.za

The Lancet. Infectious Diseases
|March 1, 2012
PubMed

Insights

Children exposed to multidrug-resistant tuberculosis (MDR-TB) need effective preventive strategies. This review examines management options for child contacts of MDR-TB cases, highlighting treatment challenges and HIV implications.

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Mycobacterial infections

Background:

  • Children exposed to multidrug-resistant (MDR) Mycobacterium tuberculosis face high risks of developing MDR tuberculosis.
  • Treatment for MDR tuberculosis is challenging due to length, cost, poor adherence, and significant morbidity/mortality.
  • Preventive treatment is established for contacts of drug-susceptible tuberculosis but understudied for MDR-TB contacts.

Purpose of the Study:

  • To review the management of child contacts exposed to MDR tuberculosis.
  • To discuss assessment, guidelines, preventive treatments, and management rationales.
  • To explore the impact of HIV infection on management strategies.

Main Methods:

  • Literature review focusing on management of child contacts of MDR tuberculosis cases.
  • Analysis of existing international guidelines and preventive treatment options.
  • Discussion of clinical management strategies and HIV co-infection considerations.

Main Results:

  • Limited data exists on preventive treatment efficacy for child contacts of MDR-TB.
  • Management strategies require careful consideration of individual risk, drug resistance profiles, and available resources.
  • HIV infection significantly complicates management decisions and treatment choices.

Conclusions:

  • There is a critical need for evidence-based guidelines for managing child contacts of MDR-TB.
  • Optimizing preventive strategies and treatment protocols is essential to reduce disease burden in this vulnerable population.
  • Further research is required to establish effective and safe interventions, particularly in co-infected individuals.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...